Related Experiment Video
Updated: Apr 22, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
AI prediction models with omics data utilization for atherosclerosis: A systematic scoping review and meta-analysis
Yunbeom Lee1, Kwanwoo Park2, Ji Hyun Lee1
1Department of Clinical Pharmacology and Therapeutics, College of Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.
Insights
Artificial intelligence (AI) prediction models (APMs) significantly outperform conventional risk prediction models (CRMs) for cardiovascular disease. This systematic review highlights AI
Area of Science:
- Cardiovascular omics research
- Artificial intelligence in precision medicine
- High-dimensional data interpretation
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Advanced methods are needed to understand CVD pathophysiology.
- Artificial intelligence (AI) applied to omics data offers potential for precision medicine.
Purpose of the Study:
- To systematically review AI technologies in cardiovascular omics research.
- To compare AI prediction models (APMs) against conventional risk prediction models (CRMs) for atherosclerosis.
Main Methods:
- Two-phase systematic review: scoping review (218 studies) and meta-analysis (38 studies).
- Meta-analysis quantified incremental performance of APMs over CRMs using difference in area under the curve (ΔAUC).
- Focus on atherosclerosis-specific studies.
Main Results:
- Significant growth observed in AI modeling and omics methodologies.
- APMs significantly outperformed CRMs (pooled ΔAUC = 0.0586, p < 0.0001).
- Moderate heterogeneity (I² = 40.02%) observed in meta-analysis.
Conclusions:
- AI prediction models demonstrate a robust performance advantage over conventional models.
- Performance benefit of APMs was consistent across various experimental designs and validation strategies.
- AI holds significant promise for advancing cardiovascular precision medicine through omics data.
Background And Aims:
Cardiovascular disease (CVD) remains a leading cause of global mortality, necessitating advanced methodologies to elucidate its complex pathophysiology. The application of artificial intelligence (AI) to interpret high-dimensional omics data offers a significant opportunity for precision medicine. This study aims to systematically review the current landscape of AI technologies in cardiovascular omics research and compare predictive performance of omics-trained AI prediction models (APMs) against conventional risk prediction models (CRMs) in atherosclerosis.
Methods:
We employed a two-phase systematic review framework. Study 1 (scoping review) mapped the broad landscape of AI applications in cardiovascular omics research by reviewing 218 eligible studies. Study 2 (meta-analysis) comprised a systematic meta-analysis of 38 distinct, atherosclerosis-specific studies to quantify the incremental performance of APMs over CRMs, assessed via the difference in area under the curve (ΔAUC).
Results:
Study 1 (scoping review) demonstrated substantial growth in AI modeling, multi-omics, and advanced omics methodologies from 2024 onwards. In Study 2 (meta-analysis), APMs significantly outperformed CRMs (pooled ΔAUC = 0.0586; 95% CI: 0.0335-0.0836; p < 0.0001) with a moderate level of between-study heterogeneity (I2 = 40.02%, Cochran's Q test p = 0.0182).
Conclusions:
Subsequent subgroup analyses revealed no significant moderator effects across differing experimental designs or validation strategies, indicating that the performance advantage of APMs remained robust across diverse analytical conditions.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction
Atherosclerosis IV: Nursing Management